Search results for: 'dect tech eu'

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

26 May 2020  |  North America  |  Market Research

US and EU-5 Custom Procedure Tray Market, Forecast to 2024

Healthcare Systems Benefit from Standardization and Efficiency

Infographics

×

Escalating healthcare costs and longer patient wait lists have put pressure on healthcare facilities to reduce operational expenses and increase efficiency. The operating room is one of the biggest cost (and revenue) centers for a healthcare facility: according to some studies, the operating room accounts for about 40Percentage of expenses in a hos...

13 Oct 2020  |  North America  |  Market Research

Increasing Adoption of Low-cost Devices with Simple Designs in Response to COVID-19 to Disrupt the US & EU-5 Ventilator Market, 2025

Rising Preference for Home-based Care, Aided by Remote Monitoring Technologies, to Drive New Growth Opportunities

Infographics

×

Revenue for the US & EU-5 ventilators market is expected to increase by 370.7% in 2020 driven by the ongoing Coronavirus 2019 (COVID-19) situation. The home care segment is expected to see a comparatively strong growth potential post-pandemic. This study assesses the revenue growth impact on different ventilator market segments. It also analyzes fu...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

The commercial vehicle industry faces common challenges, such as rising fixed costs, difficulty in ensuring immediate truck availability, prolonged delivery time, high operating costs, high fuel spend, increased repair cost, and sub-optimal asset utilisation. Telematics has been the go-to solution for industry participants in addressing these chall...

Electrification of railways is on a general upswing globally owing to many regions coming forward to promote greener rail systems and improve air quality. Replacement of diesel-powered locomotives with electric or alternative powertrains such as liquefied natural gas (LNG) and hydrogen power are becoming popular with the successful operations of hy...

16 Feb 2021  |  North America  |  Market Research

Partial, Semi-autonomous Driving and EU General Safety Regulation Set to Propel Global Driver Monitoring System Market

Future Growth Potential via Vehicle-Segment-Specific Customization Enhancing Growth Opportunities

Infographics

×

Driver distraction and drowsiness are major causes of road traffic crashes worldwide. A review for the European Commission found driver distraction to be the likely factor in 10% to 30% of road collisions in Europe each year. Driver monitoring systems (DMS) can address this critical challenge by monitoring driver drowsiness and attention. The intro...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...